Abnormal uroporphyrin levels in chronic hepatitis C virus infection

Journal of Clinical Gastroenterology

Volumn 29, Issue 4, 1999, Pages 327-331

  Martinelli, Ana L C ^a   Villanova, Marcia G ^a   Roselino, Ana M F ^a   Figueiredo, José F C ^a   Passos, Afonso D C ^a   Covas, Dimas T ^a   Zucoloto, Sérgio ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Chronic hepatitis C; Coproporphyrin; HCV; Hepatitis C virus; Porphyria cutanea tarda; Porphyrin; Uroporphyrin

Indexed keywords

COPROPORPHYRIN; PORPHYRIN; UROPORPHYRIN;

ADOLESCENT; ADULT; ARTICLE; CLINICAL FEATURE; DISEASE ASSOCIATION; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; PORPHYRIA CUTANEA TARDA; PORPHYRIN METABOLISM; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; VIRUS PATHOGENESIS;

EID: 0032745760     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004836-199912000-00006     Document Type: Article

References (29)

1. Elder GH, Lee GB, Tovey JA. Decreased activity of hepatic uroporphyrinogen decarboxylase in sporadic porphyria cutanea tarda. N Engl J Med 1978;299:274-8.
2. Grossmann ME, Poh-Fitzpatrick MB. Porphyria cutanea tarda. Diagnosis, management, and differentiation from other hepatic porphyrias. Dermatol Clin 1986;4:297-309.
3. Cortes JM, Oliva H, Paradinas FJ, Hernandez-Guio C. The pathology of the liver in porphyria cutanea tarda. Histopathology 1980;4:471-85.
4. Rocchi E, Gibertini P, Cassanelli IM, Pietrangelo A, Jensen J, Ventura E. Hepatitis B virus infection in porphyria cutanea tarda. Liver 1986;6:153-7.
5. Wissel PS, Sordillo P, Anderson KE, Sassa S, Savillo RL, Kappas A. Porphyria cutanea tarda associated with acquired immune deficiency syndrome. Am J Hematol 1987;25:107-3.
6. Scannell KA. Porphyria cutanea tarda and acquired immunodeficiency syndrome: case reports and literature review. Arch Dermatot 1990;126:1658-9.
7. Cohen PR. Porphyria cutanea tarda in human immunodeficiency virus-seropositive men: case report and literature review. J Acquir Immune Defic Syndr 1991;4:1112-7.
8. Fargion S, Piperno A, Cappellini MD, et al. Hepatitis C virus and porphyria cutanea tarda: evidence of a strong association. Hepatology 1992;16:1322-6.
9. Lacour JPH, Bodokh I, Castanet J, Bekri S, Ortonne JP. Porphyria cutanea tarda and antibodies to hepatitis C virus. J Dermatol 1993; 128:121-3.
10. DeCastro M, Sanchez J, Herrera JF, et al. Hepatitis C virus antibodies and liver disease in patients with porphyria cutanea tarda. Hepatology 1993;17:551-7.
11. Herrero C, Vicente A, Bruguera M, et al. Is hepatitis C virus infection a trigger of porphyria cutanea tarda? Lancet 1993;341: 788-9.
12. Navas S, Bosch O, Castillo I, Marriot E, Carreño V. Porphyria cutanea tarda and hepatitis C and B viruses infection: a retrospective study. Hepatology 1995;21:279-84.
13. Murphy A, Dooley S, Hillary IB, Murphy GM. HCV infection in porphyria cutanea tarda. Lancet 1993;341:1534-5.
14. Salmon P, Oakley A, Rademaker M, Duffill M. Hepatitis C virus infection and porphyria cutanea tarda in Australasia (letter). Arch Dermatol 1996;132:91.
15. Stölzel U, Köstler E, Koszka C, et al. Low prevalence of hepatitis C virus infection in porphyria cutanea tarda in Germany. Hepatology 1995;21:1500-3.
16. Martinelli ALC, Villanova MG, Roselino AMF, et al. Associação entre a infecção pelo vírus da hepatite C (VHC) e porfiria cutânea tardia (PCT). Determinação do genótipo do VHC em 6 casos (abstract). GED 1995;14:153.
17. Fernandez AA, Henry RJ, Goldenberg H. Assay of urinary porphyrins. Clin Chem 1966;12:463-74.
18. Young KKY, Resnick RM, Myers TW. Detection of hepatitis C RNA by a combined reverse transcription-polymerase chain reaction assay. J Clin Microbiol 1993;31:882-6.
19. Nolte FS, Thurmond C, Fried MW. Clinical evaluation of a combined reverse transcription-polymerase chain reaction assay for the detection of hepatitis C virus RNA. J Clin Microbiol 1995;33: 1775-8.
20. Kwok S, Higushi R. Avoiding false positives with PCR. Nature 1989;339:237-8.
21. Cribier B, Rey D, Uhl G, et al. Abnormal urinary coproporphyrin levels in patients infected by hepatitis C virus with or without human immunodeficiency virus. Arch Dermatol 1996;132:1448-52.
22. Nomura N, Zolla-Pazner S, Simberkoff M, Kim M, Sassa S, Lim HW. Abnormal serum porphyrin in patients with the acquired immunodeficiency syndrome with or without hepatitis C infection. Arch Dermatol 1996;132:906-10.
23. O'Reilly F, Darby C, Fogarty J, et al. Porphyrin metabolism in hepatitis C infection. Photodermatol Photoimmunol Photomed 1996;12:31-3.
24. Feder JN, Gnirke A, Thomas W, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996;13:399-408.
25. Riedel HD, Stremmel W. The haemochromatosis gene. J Hepatol 1997;26:941-4.
26. Roberts AG, Whatley SD, Morgan RR, Worwood M, Elder GH. Increased frequency of the haemochromatosis Cys282Tyr mutation in sporadic porphyria cutanea tarda. Lancet 1997;349: 321-3.
27. Hayashi H, Takikawa T, Nishimura N, Yano M, Isomura T, Sakamoto N. Improvement of serum aminotransferase levels after phlebotomy in patients with chronic active hepatitis C and excess hepatic iron. Am J Gastroenterol 1994;89:986-8.
28. Piperno A, Roffi L, Pozzi M, et al. Can iron depletion therapy ameliorate hepatocellular injury in anti-HCV-positive chronic hepatitis? (abstract). Gastroenterology 1992;102(suppl 2):A868.
29. Kushner JP, Steinmuller DP, Lee GR. The role of iron in the pathogenesis of porphyria cutanea tarda. J Clin Invest 1975;56: 661-7.